Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 15;21(1):127.
doi: 10.1186/s12887-021-02599-y.

Clinical characteristics of severe neonatal enterovirus infection: a systematic review

Meng Zhang  1   2 , Haoran Wang  3 , Jun Tang  4   5 , Yang He  1   2 , Tao Xiong  1   2 , Wenxing Li  1   2 , Yi Qu  1   2 , Dezhi Mu  1   2
Affiliations

Clinical characteristics of severe neonatal enterovirus infection: a systematic review

Meng Zhang et al. BMC Pediatr. .

Abstract

Background: Enterovirus (EV) is a common cause of infection in neonates. Neonates are at high risk of enterovirus infection with serious clinical manifestations and high lethality. This review systematically summarized the clinical characteristics of neonates with severe enteroviral infection to provide evidence for the identification and treatment of severe neonatal EV infection.

Methods: PubMed, Embase, and Web of Science were searched for original studies on neonates with severe EV infections from January 1, 2000, to November 27, 2020. Two reviewers independently screened the literature, extracted the data, and performed a descriptive analysis.

Results: In total, 66 articles with 237 cases of severe neonatal enterovirus infection were included. All neonates developed severe complications. Among them, 46.0% neonates had hepatitis or coagulopathy, 37.1% had myocarditis, 11.0% had meningoencephalitis, and 5.9% had other complications such as hemophagocytic lymphohistiocytosis and pulmonary hemorrhage. The lethality rate of neonates with severe infection was 30.4%. The highest lethality rate was 38.6%, which was observed in neonates with myocarditis. In 70.5% neonates, the age at the onset of symptoms was less than 7 days. Coxsackievirus B infection was seen in 52.3% neonates. The most common symptoms included temperature abnormalities (127, 53.6%), rash (88, 37.1%), poor feeding (58, 24.5%), and respiratory symptoms (52, 21.9%). The main treatment included transfusion of empirical antibiotics (127, 53.6%), blood components (100, 42.2%), intravenous immunoglobulin (IVIG; 97, 40.9%), mechanical ventilation (51, 21.5%), and extracorporeal membrane oxygenation (ECMO; 43, 18.1%). Additionally, antiviral medications pleconaril (14, 5.9%) and pocapavir (3, 1.3%) were administered.

Conclusions: Lethality was high in neonates with severe enterovirus infection, especially in those complicated with myocarditis. The most common symptoms included temperature abnormalities, rash, and poor feeding. The chief supportive treatment consisted of transfusion of blood components, mechanical ventilation, and ECMO. Empirical antibiotics and IVIG were widely used. Antiviral medications included pocapavir and pleconaril; however, more clinical evidence regarding their efficacy is needed.

Keywords: Clinical characteristics; Complications; Enterovirus infection; Lethality; Neonates; Severe.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Diagram flow of studies selection
See this image and copyright information in PMC

References

    1. CDC. Non-Polio Enterovirus. Available from: www.cdc.gov. Accessed 28 Nov 2020.
    1. Lugo D, Krogstad P. Enteroviruses in the early 21st century: new manifestations and challenges. Curr Opin Pediatr. 2016;28(1):107–113. doi: 10.1097/MOP.0000000000000303. - DOI - PMC - PubMed
    1. Noor A, Krilov LR. Enterovirus infections. Pediatr Rev. 2016;37(12):505–515. doi: 10.1542/pir.2016-0103. - DOI - PubMed
    1. Chuang YY, Huang YC. Enteroviral infection in neonates. J Microbiol Immunol Infect. 2019;52(6):851–857. doi: 10.1016/j.jmii.2019.08.018. - DOI - PubMed
    1. Marodi L. Neonatal innate immunity to infectious agents. Infect Immun. 2006;74(4):1999–2006. doi: 10.1128/IAI.74.4.1999-2006.2006. - DOI - PMC - PubMed

Publication types